Two new prenylflavonoids from Epimedii Herba and their inhibitory effects on advanced glycation end-products

Journal of Natural Medicines

Volumn 70, Issue 2, 2016, Pages 290-295

  Nakashima, Keisuke ^a   Miyashita, Hiroyuki ^a   Yoshimitsu, Hitoshi ^a   Fujiwara, Yukio ^b   Nagai, Ryoji ^c   Ikeda, Tsuyoshi ^a  

^a SOJO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c TOKAI UNIVERSITY   (Japan)

Author keywords

Advanced glycation end products; Epimedii Herba; N (carboxymethyl)lysine; N (carboxymethyl)arginine; Prenylflavonoid

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTIDIABETIC AGENT; ARGININE DERIVATIVE; COLLAGEN; EPIMEDII HERBA EXTRACT; EPIMEDOKOREANIN B; EPIMEDONIN C; EPIMEDONIN E; EPIMEDONIN F; FLAVONOID; GELATIN; LUTEOLIN; LYSINE DERIVATIVE; METHANOL; NEW DRUG; PLANT EXTRACT; PRENYLFLAVONOID DERIVATIVE; PYRIDOXAMINE; RIBOSE; UNCLASSIFIED DRUG; ARGININE; EPIMEDII FLAVONE; HERBACEOUS AGENT; LYSINE; N(6)-CARBOXYMETHYLLYSINE; N(OMEGA)-CARBOXYMETHYLARGININE;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; EPIMEDII HERBA; EPIMEDIUM; NONHUMAN; AERIAL PLANT PART; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; CHEMISTRY; DIABETES COMPLICATIONS; ISOLATION AND PURIFICATION; MALE; METABOLISM; PHYTOTHERAPY; PRENYLATION; RAT;

ANIMALS; ARGININE; DIABETES COMPLICATIONS; DRUGS, CHINESE HERBAL; EPIMEDIUM; FLAVONOIDS; GLYCOSYLATION END PRODUCTS, ADVANCED; LYSINE; MALE; PHYTOTHERAPY; PLANT COMPONENTS, AERIAL; PRENYLATION; RATS;

EID: 84958106656     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-015-0962-0     Document Type: Article

References (26)

1. Li C, Li Q, Mei Q, Lu T (2015) Pharmacological effects and pharmacokinetic properties of icariin, the major bioactive component in Herba Epimedii. Life Sci 126:57-68
2. Fan ZL, Quan QM (2012) Advances in pharmacological research of HERBA EPIMEDII. Med Plant 3(71-74):80
3. Wu H, Lien EJ, Lien LL (2003) Chemical and pharmacological investigations of Epimedium species: a survey. Prog Drug Res 60:1-57
4. Chen XJ, Tang ZH, Li XW, Xie CX, Lu JJ, Wang YT (2015) Chemical constituents, quality control, and bioactivity of epimedii folium (Yinyanghuo). Am J Chin Med 43:783-834
5. Ma H, He X, Yang Y, Li M, Hao D, Jia Z (2011) The genus epimedium: an ethnopharmacological and phytochemical review. J Ethnopharmacol 134:519-541
6. Stearn WT (1938) Epimedium and Vancouveria (Berberidaceae), a monograph. J Linn Soc Lond Bot 51:409-535
7. Chinese Pharmacopoeia Commission (2005) Pharmacopoeia of the People's Republic of China, Beijing
8. Liu D, Zeng SH, Chen JJ, Zhang YJ, Xiao G, Zhu LY, Wang Y (2013) First insights into the large genome of Epimedium sagittatum (Sieb. et Zucc) maxim, a Chinese traditional medicinal plant. Int J Mol Sci 14(13559-13576):13518
9. The Society of Japanese Pharmacopoeia (2012) The Japanese pharmacopoeia, sixteenth edition (JPXVI). Yakuji-Nippo, Tokyo
10. Guo J, Li F, Wu Q, Gong Q, Lu Y, Shi J (2010) Protective effects of icariin on brain dysfunction induced by lipopolysaccharide in rats. Phytomedicine 17:950-955
11. Ma HP, Ma XN, Ge BF, Zhen P, Zhou J, Gao YH, Xian CJ, Chen KM (2014) Icariin attenuates hypoxia-induced oxidative stress and apoptosis in osteoblasts and preserves their osteogenic differentiation potential in vitro. Cell Prolif 47:527-539
12. Zhang J, Wang YB, Ma CG, Liu T, Li WR, Gong YQ, Xin ZC (2012) Icarisid II, a PDE5 inhibitor from Epimedium wanshanense, increases cellular cGMP by enhancing NOS in diabetic ED rats corpus cavernosum tissue. Andrologia 44:87-93
13. Sell DR, Monnier VM (1990) End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest 85:380-384
14. Araki N, Ueno N, Chakrabarti B, Morino Y, Horiuchi S (1992) Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem 267:10211-10214
15. Vlassara H, Bucala R, Striker L (1994) Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70:138-151
16. ω-carboxymethylarginine as a novel acid-labile advanced glycation end product in collagen. Biochem J 347:23-27
17. ω-(carboxymethyl)arginine by a specific antibody. Ann N Y Acad Sci 1126:155-157
18. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A (1986) Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232:1629-1632
19. Booth AA, Khalifah RG, Todd P, Hudgon BG (1997) In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways. J Biol Chem 272:5430-5437
20. Nakamura Y, Kawakami M, Yoshihiro A, Miyoshi N, Ohigashi H, Kawai K, Osawa T, Uchida K (2002) Involvement of the mitochondrial death pathway in chemopreventive benzyl isothiocyanate-induced apoptosis. J Biol Chem 277:8492-8499
21. ω-(carboxymetyl)arginine. Spec Publ R Soc Chem 322:206-210
22. Nagai R, Shimasaki S, Horikoshi A, Nakano M, Nagai M, Mera K, Fujiwara Y (2010) Screening of AGE inhibitors by antibody library. Spec Publ R Soc Chem 322:211-216
23. Motomura K, Fujiwara Y, Kiyota N, Tsurushima K, Takeya M, Nohara T, Nagai R, Ikeda T (2009) Astragalosides isolated from the root of astragalus radix inhibit the formation of advanced glycation end products. J Agric Food Chem 57:7666-7672
24. Jin Q, Lee C, Lee JW, Yeon ET, Lee D, Han SB, Hong JT, Kim Y, Lee MK, Hwang BY (2014) 2-Phenoxychromones and prenylflavonoids from Epimedium koreanum and their inhibitory effects on LPS-induced nitric oxide and interleukin-1β production. J Nat Prod 77:1724-1728
25. Li WK, Zhang RY, Xiao PG (1994) Epimedokoreanin B and C from the aerial parts of Epimedium koreanum. Yaoxue Xuebao 29:835-839
26. Nagai R, Shimasaki S, Horikoshi A, Nakano M, Nagai M, Mera K, Fujiwara Y (2010) Screening of AGE inhibitors by antibody library. Spec Publ R Soc Chem 322:211-216